Cancer Genomics (WG - CG) - CLOSED in 2017

Membership

* Liaison Member from the Committee for Molecular Diagnostics (C-MD)

Mission

The WG mission is to survey the currently used and emerging technologies in clinical cancer genomics and to establish a framework to guide clinical laboratories

Terms of Reference

• Focus on guidelines for clinical laboratories performing cancer diagnosis
• Standardise clinical laboratory sequencing and bioinformatics quality for cancer genomics
• Disseminate the knowledge in the field at an international level

Current Projects

• Survey current standards and guidelines in quality assurance and regulation of clinical genomic laboratories
•  Survey existing guidelines for bioinformatics applied to genomics
• Assemble comprehensive surveys of (i) technologies and (ii) standards/regulations
•  Create a framework for clinical genomic sequencing and bioinformatic practices that are consistent with current international laboratory standards (e.g., ISO 15189)
• Organising meetings and scientific sessions on the topic of NGS technology and bioinformatics applied to cancer patients.
• Plan for Publication and presentation of the framework to stakeholders

List of Corresponding Members, nominated by National Societies